01.09.2022 • NewsAshlandR&DKunststoffe & Polymere

Ashland Expands Viatel Output in Ireland

US chemical producer Ashland is expanding its production and R&D site at the National Science Park in Mullingar, Ireland, which makes its Viatel-branded bioresorbable polymer. The upgrade, begun this summer, is expected to complete in 2024.

Expansion of the Irish facility underlines the company’s commitment to innovation in the long acting injectables space, said Ashok Kalyana, senior vice president and general manager, Life Sciences. The polymers serve as building blocks in long-acting release formulations, bioresorbable medical devices and tissue engineering scaffolds.

“Doubling both our footprint, which includes manufacturing and laboratory space and the headcount of this facility allows us to deliver cutting-edge polymer chemistry by increasing scope, capacity and capabilities, and to respond to growing customer needs with greater speed,” Seán McMahon, the company’s business manager for Viatel, added.

By its own account, Ashland can supply more than 70 GMP grades of lactide/glycolide/caprolactone copolymers within its growing Viatel portfolio, while offering custom-made polymer production to serve changing customer requirements.

“The facility expansion further establishes Ashland as an attractive employer in Ireland,” said Brandt Giffin, senior director marketing and new business development, Life Science.

Author: Dede Williams, Freelance Journalsit

© Ashland
© Ashland

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.